ACSS2 and neoplasm: The findings were notable for an decreased cytosolic to nuclear Acss2 ratio in tumor compared to benign samples (Table 1), driven mainly by the absence or reduced presence of Acss2 immunoreactivity in the cytosol of tumor tissue samples.